Sharecafe

Patrys (ASX: PAB) – Webinar presentation

James Campbell - Managing Director & CEO Patrys is focused on the development of its deoxymab platform of cell-penetrating antibodies as therapies for a range of different cancers.

James Campbell – Managing Director & CEO Patrys is focused on the development of its deoxymab platform of cell-penetrating antibodies as therapies for a range of different cancers.

Serving up fresh finance news, marker movers & expertise.
LinkedIn
Email
X

All Categories

Subscribe

get the latest